Zdrowie i gospodarka · 03/06/2004

FDA Submits Proposed Collection of Information for Study on Glucosamine and Chondroitin Sulfate

The FDA has submitted a proposed collection of information to the OMB for review, focusing on health claims for glucosamine and chondroitin sulfate related to osteoarthritis, with the goal of clarifying product use and reducing consumer misconceptions.